EditorialThe effect of anemia treatment on selected health-related quality-of-life domains: A systematic review
References (67)
- et al.
Meta-analysis in clinical trials
Control Clin Trials
(1986) - et al.
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
Kidney Int.
(2000) - et al.
The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: A double-blind, placebo-controlled trial
Am J Kidney Dis.
(1989) - et al.
Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin
Am J Kidney Dis.
(1996) - et al.
Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients
Am J Kidney Dis.
(1994) - et al.
Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients
Am J Kidney Dis.
(1989) Erythropoietin for anaemia in cancer patients
Eur J Cancer
(1993)- et al.
Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors
Ann Oncol.
(1993) - et al.
Assessment of the quality of life of patients with advanced cancer
Eur J Cancer Clin Oncol.
(1983) - et al.
The Nottingham Health Profile: Subjective health status and medical consultations
Soc Sci Med [A]
(1981)
Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system
J Pain Symptom Manage.
(1997)
Functional status and quality of life: Predictors of early mortality among patients entering treatment for end stage renal disease
J Clin Epidemiol.
(1991)
Measurement of health status. Ascertaining the minimal clinically important difference
Control Clin Trials
(1989)
The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue
Semin Hematol.
(1997)
Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice
J Clin Oncol.
(1997)
Measuring quality of life in palliative care
Semin Oncol.
(1995)
Measuring quality of life: 1995 Update
Oncology (Huntingt)
(1995)
Epoetin treatment of anemia associated with cancer therapy: A systematic review and meta-analysis of controlled clinical trials
J Natl Cancer Inst.
(2001)
Systematic reviews: Synthesis of best evidence for clinical decisions
Ann Intern Med.
(1997)
Statistical Power Analysis for the Behavioral Sciences
(1988)
Statistical aspects of the analysis of data from retrospective studies of disease
J Natl Cancer Inst.
(1959)
Statistical Methods for Meta-Analysis
(1985)
Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis
BMJ
(1990)
Quality of life improvements in CAPD patients treated with subcutaneously administered erythropoietin for anemia
Perit Dial Int.
(1992)
The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients
J Am Soc Nephrol.
(1996)
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a Phase III multicenter clinical trial
Ann Intern Med.
(1989)
Low dose erythropoietin in maintenance haemodialysis: Improvement in quality of life and reduction in true cost of haemodialysis
Aust N Z J Med.
(1991)
Study of quality of life of patients on maintenance hemodialysis before and after the use of erythropoietin [in Spanish]
Nefrologia
(2000)
Effects of haemoglobin normalization on quality of life and cardiovascular parameters in end-stage renal failure
Nephrol Dial Transplant
(2000)
Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients
J Am Soc Nephrol.
(2000)
Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction
J Am Soc Nephrol.
(1994)
Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease
Am J Nephrol.
(1992)
Cited by (0)
Copyright © 2003 Published by Elsevier Inc.